Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

Jones Comments on the Effects of Taking ADHD Medication While Pregnant

January 23, 2018 by Madi Wood

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low.

David Jones, M.D., Professor and Director, Fetal Diagnostic Center

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low. "While the data on ADHD medications is still not conclusive due to the small number of studies it appears that overall the risk of birth defects from first trimester use is minimally increased — if it is increased at all,” says Jones.

Read the full story here.